Neuralink has just received "breakthrough device" designation for its experimental BCI (brain-computer interface) implant that would restore vision to the blind.

Elon Musk's startup received the US Food and Drug Administration (FDA) "breakthrough device" designation, which is given to particular medical devices that provide treatment or diagnosis of life-threatening conditions. It's aimed at speeding up the development and review of devices that are currently under development.

The new experimental device is known as "Blindsight" and will "enable even those who have lost both eyes and their optic nerve to see" said Elon.